CHISON MEDICAL(SH:688358) Shang Hai Zheng Quan Bao·2025-11-07 21:25Core Viewpoint - The announcement details a significant equity change involving major shareholders of Wuxi Xiangsheng Medical Technology Co., Ltd., specifically regarding the reduction of shareholding by over 1% [3][4]. Group 1: Shareholder Information - The main shareholder, Mo Ruoli, along with her concerted parties, including Wuxi Xiangsheng Investment Co., Ltd., Wuxi Xiangding Investment Enterprise (Limited Partnership), Wuxi Xiangtong Investment Enterprise (Limited Partnership), and Shanghai Yude Technology Co., Ltd., is responsible for the disclosed information [2][3]. - The actual controllers of the company, Mo Shanjuo, Mo Ruoli, and Lu Jian, are identified as concerted actors [2]. Group 2: Equity Change Details - Mo Ruoli reduced her shareholding by 1,783,139 shares, representing 1.59% of the total share capital, between September 5, 2025, and November 6, 2025 [3]. - Following this reduction, the total shares held by Mo Ruoli and her concerted parties decreased from 80,723,956 shares to 78,940,817 shares, with the ownership percentage dropping from 71.99% to 70.40% [3]. Group 3: Additional Notes - This equity change is part of a previously disclosed share reduction plan by Mo Ruoli, as announced on August 15, 2025 [4]. - The reduction was executed through centralized bidding and block trading, and it does not trigger a mandatory tender offer [4]. - The equity change will not alter the controlling shareholder or actual controller of the company, nor will it significantly impact the company's governance structure or ongoing operations [5].